Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Identifieur interne : 001757 ( PubMed/Checkpoint ); précédent : 001756; suivant : 001758

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Auteurs : Lanying Du [États-Unis] ; Yuxian He ; Yusen Zhou ; Shuwen Liu ; Bo-Jian Zheng ; Shibo Jiang

Source :

RBID : pubmed:19198616

Descripteurs français

English descriptors

Abstract

Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused by a novel coronavirus, SARS-coronavirus (SARS-CoV). The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. In this Review, we highlight recent advances in the development of vaccines and therapeutics based on the S protein.

DOI: 10.1038/nrmicro2090
PubMed: 19198616


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:19198616

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The spike protein of SARS-CoV--a target for vaccine and therapeutic development.</title>
<author>
<name sortKey="Du, Lanying" sort="Du, Lanying" uniqKey="Du L" first="Lanying" last="Du">Lanying Du</name>
<affiliation wicri:level="2">
<nlm:affiliation>Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th Street, New York, NY 10065, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th Street, New York, NY 10065</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="He, Yuxian" sort="He, Yuxian" uniqKey="He Y" first="Yuxian" last="He">Yuxian He</name>
</author>
<author>
<name sortKey="Zhou, Yusen" sort="Zhou, Yusen" uniqKey="Zhou Y" first="Yusen" last="Zhou">Yusen Zhou</name>
</author>
<author>
<name sortKey="Liu, Shuwen" sort="Liu, Shuwen" uniqKey="Liu S" first="Shuwen" last="Liu">Shuwen Liu</name>
</author>
<author>
<name sortKey="Zheng, Bo Jian" sort="Zheng, Bo Jian" uniqKey="Zheng B" first="Bo-Jian" last="Zheng">Bo-Jian Zheng</name>
</author>
<author>
<name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19198616</idno>
<idno type="pmid">19198616</idno>
<idno type="doi">10.1038/nrmicro2090</idno>
<idno type="wicri:Area/PubMed/Corpus">001967</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001967</idno>
<idno type="wicri:Area/PubMed/Curation">001967</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001967</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001757</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001757</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The spike protein of SARS-CoV--a target for vaccine and therapeutic development.</title>
<author>
<name sortKey="Du, Lanying" sort="Du, Lanying" uniqKey="Du L" first="Lanying" last="Du">Lanying Du</name>
<affiliation wicri:level="2">
<nlm:affiliation>Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th Street, New York, NY 10065, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th Street, New York, NY 10065</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="He, Yuxian" sort="He, Yuxian" uniqKey="He Y" first="Yuxian" last="He">Yuxian He</name>
</author>
<author>
<name sortKey="Zhou, Yusen" sort="Zhou, Yusen" uniqKey="Zhou Y" first="Yusen" last="Zhou">Yusen Zhou</name>
</author>
<author>
<name sortKey="Liu, Shuwen" sort="Liu, Shuwen" uniqKey="Liu S" first="Shuwen" last="Liu">Shuwen Liu</name>
</author>
<author>
<name sortKey="Zheng, Bo Jian" sort="Zheng, Bo Jian" uniqKey="Zheng B" first="Bo-Jian" last="Zheng">Bo-Jian Zheng</name>
</author>
<author>
<name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name>
</author>
</analytic>
<series>
<title level="j">Nature reviews. Microbiology</title>
<idno type="eISSN">1740-1534</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Monoclonal (immunology)</term>
<term>Antibodies, Monoclonal (therapeutic use)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Humans</term>
<term>Membrane Glycoproteins (chemistry)</term>
<term>Membrane Glycoproteins (immunology)</term>
<term>Membrane Glycoproteins (physiology)</term>
<term>Peptidyl-Dipeptidase A (metabolism)</term>
<term>RNA Interference</term>
<term>RNA, Small Interfering</term>
<term>SARS Virus (chemistry)</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (physiology)</term>
<term>Severe Acute Respiratory Syndrome (pathology)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Severe Acute Respiratory Syndrome (therapy)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Envelope Proteins (chemistry)</term>
<term>Viral Envelope Proteins (immunology)</term>
<term>Viral Envelope Proteins (physiology)</term>
<term>Viral Vaccines (immunology)</term>
<term>Virus Internalization</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Anticorps monoclonaux (immunologie)</term>
<term>Anticorps monoclonaux (usage thérapeutique)</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires ()</term>
<term>Glycoprotéines membranaires (immunologie)</term>
<term>Glycoprotéines membranaires (physiologie)</term>
<term>Humains</term>
<term>Interférence par ARN</term>
<term>Peptidyl-Dipeptidase A (métabolisme)</term>
<term>Petit ARN interférent</term>
<term>Protéines de l'enveloppe virale ()</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Protéines de l'enveloppe virale (physiologie)</term>
<term>Pénétration virale</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (anatomopathologie)</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Antibodies, Monoclonal</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Peptidyl-Dipeptidase A</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antibodies, Monoclonal</term>
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Anticorps monoclonaux</term>
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Peptidyl-Dipeptidase A</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Anticorps monoclonaux</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>RNA Interference</term>
<term>RNA, Small Interfering</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Virus Internalization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires</term>
<term>Humains</term>
<term>Interférence par ARN</term>
<term>Petit ARN interférent</term>
<term>Protéines de l'enveloppe virale</term>
<term>Pénétration virale</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused by a novel coronavirus, SARS-coronavirus (SARS-CoV). The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. In this Review, we highlight recent advances in the development of vaccines and therapeutics based on the S protein.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">19198616</PMID>
<DateCompleted>
<Year>2009</Year>
<Month>03</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1740-1534</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>7</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2009</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Nature reviews. Microbiology</Title>
<ISOAbbreviation>Nat. Rev. Microbiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The spike protein of SARS-CoV--a target for vaccine and therapeutic development.</ArticleTitle>
<Pagination>
<MedlinePgn>226-36</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nrmicro2090</ELocationID>
<Abstract>
<AbstractText>Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused by a novel coronavirus, SARS-coronavirus (SARS-CoV). The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV. In this Review, we highlight recent advances in the development of vaccines and therapeutics based on the S protein.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Du</LastName>
<ForeName>Lanying</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th Street, New York, NY 10065, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Yuxian</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Yusen</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Shuwen</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zheng</LastName>
<ForeName>Bo-Jian</ForeName>
<Initials>BJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Shibo</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI068002</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI068002-03</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI 68002</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2009</Year>
<Month>02</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Nat Rev Microbiol</MedlineTA>
<NlmUniqueID>101190261</NlmUniqueID>
<ISSNLinking>1740-1526</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.15.1</RegistryNumber>
<NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.17.-</RegistryNumber>
<NameOfSubstance UI="C413524">angiotensin converting enzyme 2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="Y">SARS Virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>143</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2009</Year>
<Month>2</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2009</Year>
<Month>2</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2009</Year>
<Month>3</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">19198616</ArticleId>
<ArticleId IdType="pii">nrmicro2090</ArticleId>
<ArticleId IdType="doi">10.1038/nrmicro2090</ArticleId>
<ArticleId IdType="pmc">PMC2750777</ArticleId>
<ArticleId IdType="mid">NIHMS132953</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>FEBS Lett. 2004 Feb 27;560(1-3):141-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14988013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Apr;78(7):3572-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15016880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 2004 Feb;82(2):152-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15042239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15010527</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Mar 20;363(9413):938-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15043961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2004 Apr 1;428(6982):561-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15024391</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 May;78(9):4552-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15078936</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2004 Apr 30;304(5671):659-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15118129</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15096611</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 May 14;279(20):20836-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14996844</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pathol. 2004 Jun;203(2):622-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15141376</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jun;78(11):5642-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15140961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jun;78(12):6134-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15163706</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2004 Jul;73(3):332-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15170625</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15150417</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2008 Sep;89(Pt 9):2136-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18753223</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Oncol. 1999 Dec;26(6):683-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10606261</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2002 Jul 25;418(6896):430-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12087357</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Feb;77(4):2530-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12551991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15474494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Nov 26;324(4):1186-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15504339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2004 Oct;10(10):1774-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15504263</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Nov;78(22):12672-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15507655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1993 Sep 9;365(6442):113</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8371754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Jul 2;319(3):746-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15184046</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jul;78(13):7217-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15194798</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Jun 26;363(9427):2122-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15220033</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Jun 26;363(9427):2139-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15220038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15210961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Ther. 2004 Jun;9(3):365-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15259899</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Aug;10(8):871-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15247913</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2004 Sep 15;190(6):1119-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15319862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chem Biol. 2004 Sep;11(9):1293-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15380189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Oct;78(20):11334-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15452254</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16116101</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2005 Sep;11(9):944-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16116432</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Comb Chem. 2005 Sep-Oct;7(5):648-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16153058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Sep 16;309(5742):1864-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16166518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16169905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Immunol. 2004 Apr;1(2):119-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16212898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biomed Sci. 2005 Oct;12(5):711-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16132115</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16339739</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Mar 1;193(5):685-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16453264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2006 Feb 10;281(6):3198-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16339146</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2006 Feb 13;24(7):863-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16191455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2006 May 26;344(1):106-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16615996</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2006 Apr 28;281(17):11965-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16507566</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 2006 May 1;580(10):2414-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16638566</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2006 May 15;176(10):6085-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16670317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Jun;80(12):5757-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16731915</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2006 Jun 9;281(23):15829-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16597622</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2006 Jul 1;43(1):e1-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16758408</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2006 Jun 29;24(26):5498-508</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16725238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2006 Jun 20;350(1):15-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16510163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Jul;80(14):6794-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16809285</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2006 Sep 15;353(1):6-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16793110</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Exp Med Biol. 2006;581:235-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17037535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Exp Med Biol. 2006;581:335-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17037556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Microbiol. 2006;6:88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17020602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Jan 2;25(1):136-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16919855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Jan 8;25(4):729-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17049691</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2006;12(35):4555-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17168761</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2006 Dec;3(12):e525</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17194199</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1948-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12748314</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2003 Jun;111(11):1605-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12782660</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 Oct 10;302(5643):276-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12958366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Oct 25;362(9393):1353-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14585636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14651994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Jan 30;314(1):235-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14715271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Biochim Biophys Sin (Shanghai). 2004 Jan;36(1):37-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14732873</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14670965</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2004 Feb;4(2):64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14959754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14983044</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1994 Sep;68(9):5403-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7520090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7937889</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1998 May 29;93(5):681-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9630213</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Membr Biol. 1999 Jan-Mar;16(1):3-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10332732</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15748-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15496474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15530413</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Nov 19;279(47):49414-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15345712</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Life Sci. 2004 Nov;61(21):2738-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15549175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2004 Oct;14(5):400-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15450134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Feb;79(3):1635-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15650189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Feb;79(3):1906-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15650214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2005 Jan;65(1):45-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15652970</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):797-801</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15642942</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Med. 2005;56:357-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15660517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2005 Mar 25;328(4):979-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15707974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Mar;79(5):2678-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15708987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Mar;79(6):3289-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15731223</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Mar;79(6):3401-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15731234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Discov Today. 2005 Mar 1;10(5):345-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15749283</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2005 Mar 30;334(1):74-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15749124</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2005 Mar 18;23(17-18):2273-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15755610</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chin Med J (Engl). 2005 Mar 20;118(6):446-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15788124</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2005 Apr 15;174(8):4908-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15814718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2005 Apr 25;335(1):34-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15823604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gene Ther. 2005 May;12(9):751-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15772689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 May;79(10):5900-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15857975</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Jun;79(11):7195-206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15890958</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Ther. 2005;10(3):393-403</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15918330</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2005 Apr 20;24(8):1634-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15791205</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pathol. 2005 Jul;206(3):251-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15892035</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Comput Biol Chem. 2005 Jun;29(3):254-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15979045</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2005 Aug;167(2):455-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16049331</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2005 Aug 19;280(33):29588-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15980414</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16081529</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2006;1:e24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17183651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2007;13(2):143-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17269924</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Mar 8;25(12):2173-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17227689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2007 Mar;73(3):219-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17112601</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Environ Sci. 2006 Dec;19(6):445-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17319269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Apr 12;25(15):2832-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17092615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2007 Apr;170(4):1136-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17392154</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 May;81(9):4694-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17314167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2007 Apr 25;361(1):93-102</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17161858</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2007 May 10;361(2):304-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17210170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2007 Jan;3(1):e5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17222058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2007 Jul 20;359(1):174-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17533109</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Jul;81(14):7410-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17507479</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12123-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17620608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Aug;81(16):8722-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17522231</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Sep 28;25(39-40):6981-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17709158</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Nov;81(21):12029-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17715238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Jan;82(1):588-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17942557</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2008 Jan 15;180(2):948-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18178835</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Feb;82(3):1414-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18032498</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2008 Mar 20;26(13):1644-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18289745</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Apr;82(7):3220-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18199635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2008 Apr;133(1):101-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17451827</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2008 Apr;133(1):74-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17451830</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2008 Apr;133(1):4-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17825937</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Lett. 2008 Jun 15;118(1):65-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18440652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2008 Aug;39(2):142-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18314540</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbes Infect. 2008 Jul;10(8):908-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18606245</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Sep;82(17):8887-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18562523</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Sep;82(17):8721-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18579604</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>État de New York</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="He, Yuxian" sort="He, Yuxian" uniqKey="He Y" first="Yuxian" last="He">Yuxian He</name>
<name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name>
<name sortKey="Liu, Shuwen" sort="Liu, Shuwen" uniqKey="Liu S" first="Shuwen" last="Liu">Shuwen Liu</name>
<name sortKey="Zheng, Bo Jian" sort="Zheng, Bo Jian" uniqKey="Zheng B" first="Bo-Jian" last="Zheng">Bo-Jian Zheng</name>
<name sortKey="Zhou, Yusen" sort="Zhou, Yusen" uniqKey="Zhou Y" first="Yusen" last="Zhou">Yusen Zhou</name>
</noCountry>
<country name="États-Unis">
<region name="État de New York">
<name sortKey="Du, Lanying" sort="Du, Lanying" uniqKey="Du L" first="Lanying" last="Du">Lanying Du</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001757 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001757 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:19198616
   |texte=   The spike protein of SARS-CoV--a target for vaccine and therapeutic development.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:19198616" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021